Monday May 24, 2010 3:10 pm
Prescription Drugs Found Near Simon Monjack
Prescription drugs were found close to Simon Monjack’s body.
The British screenwriter - whose wife Brittany Murphy died in December aged just 32 - was discovered “unresponsive” in the bedroom of his Hollywood home last night and Los Angeles coroners are currently investigating why the 39-year-old passed away.
Los Angeles County Assistant Chief Coroner Ed Winter said, “There were some prescription drugs found that belonged to Mr. Monjack, and we’ll have an ongoing investigation. Cause of death is pending, and there will be an autopsy after a day or so, and pending toxicology reports, we’ll be releasing the results after we get all those tests back. The family is devastated at this time, and it is under investigation.”
According to the coroner, Simon’s body was found in the master bedroom and there “were no illicit drugs location - just prescription medications,” though he declined to say what they were. Simon’s death will not be investigated by police as there are no suspicious circumstances surrounding his passing.
“The preliminary cause of death for Mr. Monjack seems to be natural causes. No weapons were found at the scene. LAPD will not be involved in the investigation, since there was no indication of foul play or criminal activity,” Los Angeles Police Department Sergeant Louis Lozano said.
- Related Tags:
- breaking news, brittany murphy, brittany murphy's husband dead, brittany murphy's husband dead, brittany murphy's husband dead, brittany murphy's husband dead, brittany murphy's husband dead, coroner, death, deaths, drugs, prescription drugs, prescription medication, simon monjack, simon monjack found dead
Advertisement
Advertisement
Advertisement
© Gear Live Media, LLC. 2007 – User-posted content, unless source is quoted, is licensed under a Creative Commons Public Domain License. Gear Live graphics, logos, designs, page headers, button icons, videos, articles, blogs, forums, scripts and other service names are the trademarks of Gear Live Inc.
Comments: